ԱՓՖ արգելակիչներ (Armenian Wikipedia)

Analysis of information sources in references of the Wikipedia article "ԱՓՖ արգելակիչներ" in Armenian language version.

refsWebsite

Global rank Armenian rank

55nih.gov

4^th place

3^rd place

54doi.org

2^nd place

4^th place

10archive.org

6^th place

4worldcat.org

5^th place

10^th place

4web.archive.org

1^st place

3harvard.edu

18^th place

38^th place

2handle.net

102^nd place

2,318^th place

2rxmed.com

low place

2medscape.com

719^th place

149^th place

2bmj.com

1,226^th place

503^rd place

1nice.org.uk

3,258^th place

697^th place

1unimi.it

9,889^th place

low place

1cvpharmacology.com

low place

1openanesthesia.org

low place

1medicinenet.com

3,840^th place

1,080^th place

1patents.google.com

1,182^nd place

4,036^th place

1tripanswers.org

low place

1globalrph.com

low place

1consumerreports.org

4,720^th place

3,744^th place

1unideb.hu

low place

archive.org

Kester, Mark; Karpa, Kelly D.; Vrana, Kent E. (2012). «Cardiovascular System». Elsevier's Integrated Review Pharmacology. Elsevier. էջեր 125–151. doi:10.1016/b978-0-323-07445-2.00008-2. ISBN 978-0-323-07445-2. «ACE inhibitors also slow progression of kidney disease in patients with diabetic nephropathies. Renal benefits are probably a result of improved renal hemodynamics from decreased glomerular arteriolar resistance.»
Bakris GL, Siomos M, Richardson D, Janssen I, Bolton WK, Hebert L, Agarwal R, Catanzaro D (2000 թ․ նոյեմբեր). «ACE inhibition or angiotensin receptor blockade: impact on potassium in renal failure. VAL-K Study Group». Kidney International. 58 (5): 2084–92. doi:10.1111/j.1523-1755.2000.00381.x. PMID 11044229.
Jandeleit-Dahm K, Cooper ME (2006 թ․ սեպտեմբեր). «Hypertension and diabetes: role of the renin–angiotensin system». Endocrinol Metab Clin North Am. 35 (3): 469–90, vii. doi:10.1016/j.ecl.2006.06.007. PMID 16959581.
Gradman, Alan H.; Traub, Darren (2007). «Angiotensin-Converting Enzyme Inhibitors». Comprehensive Hypertension. Elsevier. էջեր 985–1001. doi:10.1016/b978-0-323-03961-1.50083-0. ISBN 978-0-323-03961-1. «Despite the lack of long-term suppression in plasma angiotensin II levels, they maintain their BP-lowering effect without the development of tolerance. Importantly, ACE inhibitors do not interfere with cognitive function or cardiovascular reflexes.»
Hoogwerf BJ, Young JB (2000). «The HOPE study. Ramipril lowered cardiovascular risk, but vitamin E did not». Cleveland Clinic Journal of Medicine. 67 (4): 287–93. doi:10.3949/ccjm.67.4.287. PMID 10780101.
Binkley PF, Haas GJ, Starling RC, Nunziata E, Hatton PA, Leier CV, Cody RJ (1993 թ․ մարտի 1). «Sustained augmentation of parasympathetic tone with angiotensin-converting enzyme inhibition in patients with congestive heart failure». J Am Coll Cardiol. 21 (3): 655–61. doi:10.1016/0735-1097(93)90098-L. PMID 8436747.
Minervini, F.; Algaron, F.; Rizzello, C. G.; Fox, P. F.; Monnet, V. (2003). «Angiotensin I-Converting-Enzyme-Inhibitory and Antibacterial Peptides from Lactobacillus helveticus PR4 Proteinase-Hydrolyzed Caseins of Milk from Six Species». Applied and Environmental Microbiology. 69 (9): 5297–5305. doi:10.1128/AEM.69.9.5297-5305.2003. PMC 194939. PMID 12957917.
Finnegan PM, Gleason BL (2003). «Combination ACE inhibitors and angiotensin II receptor blockers for hypertension». Annals of Pharmacotherapy. 37 (6): 886–9. doi:10.1345/aph.1C393. PMID 12773079.
Hata Y, Yamamoto M, Ohni M, Nakajima K, Nakamura Y, Takano T (1996). «A placebo-controlled study of the effect of sour milk on blood pressure in hypertensive subjects». The American Journal of Clinical Nutrition. 64 (5): 767–71. doi:10.1093/ajcn/64.5.767. PMID 8901799.
Nakamura Y, Yamamoto N, Sakai K, Takano T (1995). «Antihypertensive effect of sour milk and peptides isolated from it that are inhibitors to angiotensin I-converting enzyme». Journal of Dairy Science. 78 (6): 1253–7. doi:10.3168/jds.S0022-0302(95)76745-5. PMID 7673515.

bmj.com

Caldeira, Daniel (Summer 2012). «Risk of pneumonia associated with use of angiotensin converting enzyme inhibitors and angiotensin receptor blockers: systematic review and meta-analysis». BMJ. 345: 4260. doi:10.1136/bmj.e4260. PMC 3394697. PMID 22786934.

bestpractice.bmj.com

«Psychogenic polydipsia – Management – Emerging treatments». British Medical Journal. 2016 թ․ մայիսի 5. Արխիվացված է օրիգինալից 2021 թ․ օգոստոսի 27-ին. Վերցված է 2016 թ․ հոկտեմբերի 28-ին.

consumerreports.org

Treating High Blood Pressure and Heart Disease: the ACE Inhibitors. Consumer Reports Health Best Buy Drugs. June 2009.

cvpharmacology.com

«ACE I». cvpharmacology.

doi.org

Kaplan's Essentials of Cardiac Anesthesia. Elsevier. 2018. doi:10.1016/c2012-0-06151-0. ISBN 978-0-323-49798-5. «Mechanisms of Action:ACE inhibitors act by inhibiting one of several proteases responsible for cleaving the decapeptide Ang I to form the octapeptide Ang II. Because ACE is also the enzyme that degrades bradykinin, ACE inhibitors increase circulating and tissue levels of bradykinin (Fig. 8.4).»
Aronow, Wilbert S. (2010). «Cardiac Arrhythmias». Brocklehurst's Textbook of Geriatric Medicine and Gerontology. Elsevier. էջեր 327–337. doi:10.1016/b978-1-4160-6231-8.10045-5. ISBN 978-1-4160-6231-8. «Angiotensin-converting enzyme inhibitors ACE inhibitors have been demonstrated to reduce sudden cardiac death in some studies of persons with CHF.24,56»
Byrd, James Brian; Ram, C. Venkata S.; Lerma, Edgar V. (2019). «Pharmacologic treatment of hypertension». Nephrology Secrets. Elsevier. էջեր 477–482. doi:10.1016/b978-0-323-47871-7.00078-2. ISBN 978-0-323-47871-7. «ACE inhibitors inhibit the conversion of angiotensin I to angiotensin II, thereby producing vasodilation and lowering BP. Because the hydrolysis of bradykinin is also inhibited by these drugs, cough (7% to 12%) can occur.»
Kester, Mark; Karpa, Kelly D.; Vrana, Kent E. (2012). «Cardiovascular System». Elsevier's Integrated Review Pharmacology. Elsevier. էջեր 125–151. doi:10.1016/b978-0-323-07445-2.00008-2. ISBN 978-0-323-07445-2. «ACE inhibitors also slow progression of kidney disease in patients with diabetic nephropathies. Renal benefits are probably a result of improved renal hemodynamics from decreased glomerular arteriolar resistance.»
Bangalore, S; Fakheri, R; Wandel, S; Toklu, B; Wandel, J; Messerli, FH (2017 թ․ հունվարի 19). «Renin angiotensin system inhibitors for patients with stable coronary artery disease without heart failure: systematic review and meta-analysis of randomized trials». BMJ (Clinical Research Ed.). 356: j4. doi:10.1136/bmj.j4. PMC 5244819. PMID 28104622.
Caldeira, D.; Alarcao, J.; Vaz-Carneiro, A.; Costa, J. (2012 թ․ հուլիսի 11). «Risk of pneumonia associated with use of angiotensin converting enzyme inhibitors and angiotensin receptor blockers: systematic review and meta-analysis». The BMJ. BMJ. 345 (jul11 1): e4260–e4260. doi:10.1136/bmj.e4260. ISSN 1756-1833. PMC 3394697. PMID 22786934.
Caldeira, Daniel (Summer 2012). «Risk of pneumonia associated with use of angiotensin converting enzyme inhibitors and angiotensin receptor blockers: systematic review and meta-analysis». BMJ. 345: 4260. doi:10.1136/bmj.e4260. PMC 3394697. PMID 22786934.
Dundas, Brian; Harris, Melissa; Narasimhan, Meera (2007 թ․ հուլիսի 3). «Psychogenic polydipsia review: Etiology, differential, and treatment». Current Psychiatry Reports (անգլերեն). 9 (3): 236–241. doi:10.1007/s11920-007-0025-7. ISSN 1523-3812. PMID 17521521.
Greendyke, R. M.; Bernhardt, A. J.; Tasbas, H. E.; Lewandowski, K. S. (1998 թ․ ապրիլի 1). «Polydipsia in chronic psychiatric patients: therapeutic trials of clonidine and enalapril». Neuropsychopharmacology. 18 (4): 272–281. doi:10.1016/S0893-133X(97)00159-0. ISSN 0893-133X. PMID 9509495.
Sebastian, C. S.; Bernardin, A. S. (1990 թ․ ապրիլի 1). «Comparison of enalapril and captopril in the management of self-induced water intoxication». Biological Psychiatry. 27 (7): 787–790. doi:10.1016/0006-3223(90)90594-r. ISSN 0006-3223. PMID 2183881.
Sidorenkov G, Navis G (2014). «Safety of ACE inhibitor therapies in patients with chronic kidney disease». Expert Opinion on Drug Safety. 13 (10): 1383–1395. doi:10.1517/14740338.2014.951328. PMID 25148900.
Tucker, Bryan M.; Perazella, Mark A. (2019). «Medications: 3. What are the major adverse effects on the kidney of ACE inhibitors and ARBs?». Nephrology Secrets. Elsevier. էջեր 78–83. doi:10.1016/b978-0-323-47871-7.00019-8. ISBN 978-0-323-47871-7. «due to inhibition of angiotensin II production by ACE inhibitors or competitive antagonism of the angiotensin II receptor by ARBs... results in loss of angiotensin II–induced efferent arteriolar tone, leading to a drop in glomerular filtration fraction and GFR. The efferent arteriolal vasodilation reduces intraglomerular hypertension (and pressure-related injury) and maintains perfusion (and oxygenation) of the peritubular capillaries.»
Thomas MC (2000). «Diuretics, ACE inhibitors and NSAIDs—the triple whammy». The Medical Journal of Australia. 172 (4): 184–5. doi:10.5694/j.1326-5377.2000.tb125548.x. PMID 10772593.
Cohn JN, Kowey PR, Whelton PK, Prisant LM (2000). «New guidelines for potassium replacement in clinical practice: a contemporary review by the National Council on Potassium in Clinical Practice». Archives of Internal Medicine. 160 (16): 2429–36. doi:10.1001/archinte.160.16.2429. PMID 10979053.
OKUMURA, Hiromi; NISHIMURA, Eriko; KARIYA, Satoru; OHTANI, Michiteru; UCHINO, Katsuyoshi; FUKATSU, Tohru; ODANAKA, Jun; TAKAHASHI, Tsuyoshi; WATANABE, Kiyoshi; ITOH, Takashi; HASHIGUCHI, Masayuki; ECHIZEN, Hirotoshi; RIKIHISA, Tadaaki (2001 թ․ մարտի 1). «No Relation between Angiotensin-Converting Enzyme (ACE) Inhibitor-Induced Cough and ACE Gene Polymorphism, Plasma Bradykinin, Substance P and ACE Inhibitor Concentration in Japanese Patients». Yakugaku Zasshi. 121 (3): 253–257. doi:10.1248/yakushi.121.253. PMID 11265121.
Vukadinović, D; Vukadinović, AN; Lavall, D; Laufs, U; Wagenpfeil, S; Böhm, M (2019 թ․ մարտ). «Rate of Cough During Treatment With Angiotensin-Converting Enzyme Inhibitors: A Meta-Analysis of Randomized Placebo-Controlled Trials». Clinical Pharmacology and Therapeutics. 105 (3): 652–660. doi:10.1002/cpt.1018. PMID 29330882.
Bezalel, S; Mahlab-Guri, K; Asher, I; Werner, B; Sthoeger, ZM (2015 թ․ փետրվար). «Angiotensin-converting enzyme inhibitor-induced angioedema». The American Journal of Medicine. 128 (2): 120–5. doi:10.1016/j.amjmed.2014.07.011. PMID 25058867.
Molinaro G, Cugno M, Perez M, Lepage Y, Gervais N, Agostoni A, Adam A (2002). «Angiotensin-converting enzyme inhibitor-associated angioedema is characterized by a slower degradation of des-arginine(9)-bradykinin» (PDF). The Journal of Pharmacology and Experimental Therapeutics. 303 (1): 232–7. doi:10.1124/jpet.102.038067. hdl:2434/161106. PMID 12235256.
Bullo M, Tschumi S, Bucher BS, Bianchetti MG, Simonetti GD (2012). «Pregnancy Outcome Following Exposure to Angiotensin-Converting Enzyme Inhibitors or Angiotensin Receptor Antagonists: A Systematic Review». Hypertension. 60 (2): 444–50. doi:10.1161/HYPERTENSIONAHA.112.196352. PMID 22753220.
Cooper WO, Hernandez-Diaz S, Arbogast PG, Dudley JA, Dyer S, Gideon PS, Hall K, Ray WA (2006). «Major congenital malformations after first-trimester exposure to ACE inhibitors». The New England Journal of Medicine. 354 (23): 2443–51. doi:10.1056/NEJMoa055202. PMID 16760444.
Bakris GL, Siomos M, Richardson D, Janssen I, Bolton WK, Hebert L, Agarwal R, Catanzaro D (2000 թ․ նոյեմբեր). «ACE inhibition or angiotensin receptor blockade: impact on potassium in renal failure. VAL-K Study Group». Kidney International. 58 (5): 2084–92. doi:10.1111/j.1523-1755.2000.00381.x. PMID 11044229.
Sear, John W. (2019). «Antihypertensive Drugs and Vasodilators». Pharmacology and Physiology for Anesthesia. Elsevier. էջեր 535–555. doi:10.1016/b978-0-323-48110-6.00026-0. ISBN 978-0-323-48110-6. «Coadministration of nonsteroidal anti-inflammatory drugs (NSAIDs [cyclooxygenase inhibitors]) can reduce the hypotensive effects of ACE inhibitors. ACE inhibitors can inhibit the excretion of lithium and can result in lithium toxicity. Because these drugs do not affect the breakdown of kinins (as is seen with the ACE inhibitors), patients do not develop episodes of coughing and rarely develop angioneurotic edema.»
Byrd, James Brian; Ram, C. Venkata S.; Lerma, Edgar V. (2019). «Pharmacologic treatment of hypertension». Nephrology Secrets. Elsevier. էջեր 477–482. doi:10.1016/b978-0-323-47871-7.00078-2. ISBN 978-0-323-47871-7. «Angioedema (0.7%) can also occur via pathobiology that remains obscure, and its occurrence can be life-threatening. ...their efficacy is reduced by dietary or other sources of sodium, and renal function may be further threatened if given with NSAIDs.»
Jandeleit-Dahm K, Cooper ME (2006 թ․ սեպտեմբեր). «Hypertension and diabetes: role of the renin–angiotensin system». Endocrinol Metab Clin North Am. 35 (3): 469–90, vii. doi:10.1016/j.ecl.2006.06.007. PMID 16959581.
Wang W, McKinnie SM, Farhan M, Paul M, McDonald T, McLean B, Llorens-Cortes C, Hazra S, Murray AG, Vederas JC, Oudit GY (2016 թ․ մայիս). «Angiotensin Converting Enzyme 2 Metabolizes and Partially Inactivates Pyrapelin-13 and Apelin-17: Physiological Effects in the Cardiovascular System». Hypertension. 68 (2): 365–77. doi:10.1161/HYPERTENSIONAHA.115.06892. PMID 27217402.
Gradman, Alan H.; Traub, Darren (2007). «Angiotensin-Converting Enzyme Inhibitors». Comprehensive Hypertension. Elsevier. էջեր 985–1001. doi:10.1016/b978-0-323-03961-1.50083-0. ISBN 978-0-323-03961-1. «Despite the lack of long-term suppression in plasma angiotensin II levels, they maintain their BP-lowering effect without the development of tolerance. Importantly, ACE inhibitors do not interfere with cognitive function or cardiovascular reflexes.»
Hoogwerf BJ, Young JB (2000). «The HOPE study. Ramipril lowered cardiovascular risk, but vitamin E did not». Cleveland Clinic Journal of Medicine. 67 (4): 287–93. doi:10.3949/ccjm.67.4.287. PMID 10780101.
Ajayi AA, Campbell BC, Howie CA, Reid JL (1985). «Acute and Chronic Effects of the Converting Enzyme Inhibitors Enalapril and Lisinopril on Reflex Control of Heart Rate in Normotensive Man». Journal of Hypertension. 3 (1): 47–53. doi:10.1097/00004872-198502000-00008. PMID 2987341.
Binkley PF, Haas GJ, Starling RC, Nunziata E, Hatton PA, Leier CV, Cody RJ (1993 թ․ մարտի 1). «Sustained augmentation of parasympathetic tone with angiotensin-converting enzyme inhibition in patients with congestive heart failure». J Am Coll Cardiol. 21 (3): 655–61. doi:10.1016/0735-1097(93)90098-L. PMID 8436747.
Adigun AQ, Ajayi AA (2001). «The effects of enalapril-digoxin-diuretic combination therapy on nutritional and anthropometric indices in chronic congestive heart failure: preliminary findings in cardiac cachexia». European Journal of Heart Failure. 3 (3): 359–63. doi:10.1016/S1388-9842(00)00146-X. PMID 11378008.
Anker SD, Ponikowski P, Varney S, Chua TP, Clark AL, Webb-Peploe KM, Harrington D, Kox WJ, Poole-Wilson PA, Coats AJ (1997). «Wasting as independent risk factor for mortality in chronic heart failure». The Lancet. 349 (9058): 1050–3. doi:10.1016/S0140-6736(96)07015-8. PMID 9107242.
von Haehling S, Morley JE, Anker SD (2010 թ․ դեկտեմբեր). «An overview of sarcopenia: facts and numbers on prevalence and clinical impact». J Cachexia Sarcopenia Muscle. 1 (2): 129–133. doi:10.1007/s13539-010-0014-2. PMC 3060646. PMID 21475695.
Shibata, Shigeru; Fujita, Toshiro (2018). «Renin Angiotensin Aldosterone System Blockers». Hypertension: A Companion to Braunwald's Heart Disease. Elsevier. էջեր 230–241. doi:10.1016/b978-0-323-42973-3.00024-x. ISBN 978-0-323-42973-3. «ACE inhibitors are classified according to the chemical structure of the site of binding (sulfhydryl, phosphinyl, carboxyl) to the active center of ACE.»
Kumar R, Chaudhary K, Sharma M, Nagpal G, Chauhan JS, Singh S, Gautam A, Raghava GP (2015). «AHTPDB: a comprehensive platform for analysis and presentation of antihypertensive peptides». Nucleic Acids Res. 43 (Database issue): D956–62. doi:10.1093/nar/gku1141. PMC 4383949. PMID 25392419.
FitzGerald RJ, Murray BA, Walsh DJ (2004). «Hypotensive peptides from milk proteins». The Journal of Nutrition. 134 (4): 980S–8S. doi:10.1093/jn/134.4.980S. PMID 15051858.
Aihara K, Kajimoto O, Hirata H, Takahashi R, Nakamura Y (2005). «Effect of powdered fermented milk with Lactobacillus helveticus on subjects with high-normal blood pressure or mild hypertension». Journal of the American College of Nutrition. 24 (4): 257–65. doi:10.1080/07315724.2005.10719473. PMID 16093403.
Minervini, F.; Algaron, F.; Rizzello, C. G.; Fox, P. F.; Monnet, V. (2003). «Angiotensin I-Converting-Enzyme-Inhibitory and Antibacterial Peptides from Lactobacillus helveticus PR4 Proteinase-Hydrolyzed Caseins of Milk from Six Species». Applied and Environmental Microbiology. 69 (9): 5297–5305. doi:10.1128/AEM.69.9.5297-5305.2003. PMC 194939. PMID 12957917.
The Acute Infarction Ramipril Efficacy (AIRE) Study Investigators (1993 թ․ հոկտեմբեր). «Effect of ramipril on mortality and morbidity of survivors of acute myocardial infarction with clinical evidence of heart failure». Lancet. 342 (8875): 821–8. doi:10.1016/0140-6736(93)92693-N. PMID 8104270.
van Vark LC, Bertrand M, Akkerhuis KM, Brugts JJ, Fox K, Mourad JJ, Boersma E (2012). «Angiotensin-converting enzyme inhibitors reduce mortality in hypertension: a meta-analysis of randomized clinical trials of renin–angiotensin–aldosterone system inhibitors involving 158,998 patients». Eur Heart J. 33 (16): 2088–97. doi:10.1093/eurheartj/ehs075. PMC 3418510. PMID 22511654.
Dimopoulos NA, Salukhe TV, Coats AJ, Mayet J, Piepoli M, Francis DP (2004). «Meta-analyses of mortality and morbidity effects of an angiotensin receptor blocker in patients with chronic heart failure already receiving an ACE inhibitor (alone or with a beta-blocker)». Int J Cardiol. 93 (2): 105–111. doi:10.1016/j.ijcard.2003.10.001. PMID 14975535.
Luno J, Praga M, de Vinuesa SG (2005). «The reno-protective effect of the dual blockade of the renin angiotensin system (RAS)». Current Pharmaceutical Design. 11 (10): 1291–300. doi:10.2174/1381612053507413. PMID 15853685.
van de Wal RM, van Veldhuisen DJ, van Gilst WH, Voors AA (2005). «Addition of an angiotensin receptor blocker to full-dose ACE-inhibition: controversial or common sense?». European Heart Journal. 26 (22): 2361–7. doi:10.1093/eurheartj/ehi454. PMID 16105846.
ONTARGET Investigators; Yusuf, S; Teo, KK; Pogue, J; Dyal, L; Copland, I; Schumacher, H; Dagenais, G; Sleight, P; Anderson, C (2008 թ․ ապրիլի 10). «Telmisartan, ramipril, or both in patients at high risk for vascular events» (PDF). The New England Journal of Medicine. 358 (15): 1547–59. doi:10.1056/NEJMoa0801317. hdl:2437/81925. PMID 18378520.
Finnegan PM, Gleason BL (2003). «Combination ACE inhibitors and angiotensin II receptor blockers for hypertension». Annals of Pharmacotherapy. 37 (6): 886–9. doi:10.1345/aph.1C393. PMID 12773079.
Krum H, Carson P, Farsang C, Maggioni AP, Glazer RD, Aknay N, Chiang YT, Cohn JN (2004). «Effect of valsartan added to background ACE inhibitor therapy in patients with heart failure: results from Val-HeFT». European Journal of Heart Failure. 6 (7): 937–45. doi:10.1016/j.ejheart.2004.09.005. PMID 15556056.
Solomon SD, Skali H, Anavekar NS, Bourgoun M, Barvik S, Ghali JK, Warnica JW, Khrakovskaya M, Arnold JM, Schwartz Y, Velazquez EJ, Califf RM, McMurray JV, Pfeffer MA (2005). «Changes in Ventricular Size and Function in Patients Treated with Valsartan, Captopril, or Both After Myocardial Infarction». Circulation. 111 (25): 3411–3419. doi:10.1161/CIRCULATIONAHA.104.508093. PMID 15967846.
Yang Y, Ohta K, Shimizu M, Nakai A, Kasahara Y, Yachie A, Koizumi S (2005 թ․ հուլիս). «Treatment with low-dose angiotensin-converting enzyme inhibitor (ACEI) plus angiotensin II receptor blocker (ARB) in pediatric patients with IgA nephropathy». Clinical Nephrology. 64 (1): 35–40. doi:10.5414/CNP64035. PMID 16047643.
Ferreira SH (1965 թ․ փետրվար). «A bradykinin-potentiating factor (bpf) present in the venom of bothrops jararaca». Br J Pharmacol Chemother. 24 (1): 163–9. doi:10.1111/j.1476-5381.1965.tb02091.x. PMC 1704050. PMID 14302350.
Ng KK, Vane JR (1967). «Conversion of Angiotensin I to Angiotensin II». Nature. 216 (5117): 762–6. Bibcode:1967Natur.216..762N. doi:10.1038/216762a0. PMID 4294626.
Ng KK, Vane JR (1968). «Fate of Angiotensin I in the Circulation». Nature. 218 (5137): 144–50. Bibcode:1968Natur.218..144N. doi:10.1038/218144a0. PMID 4296306.
Ng KK, Vane JR (1970). «Some Properties of Angiotensin Converting Enzyme in the Lung in vivo». Nature. 225 (5238): 1142–4. Bibcode:1970Natur.225.1142N. doi:10.1038/2251142b0. PMID 4313869.
Hata Y, Yamamoto M, Ohni M, Nakajima K, Nakamura Y, Takano T (1996). «A placebo-controlled study of the effect of sour milk on blood pressure in hypertensive subjects». The American Journal of Clinical Nutrition. 64 (5): 767–71. doi:10.1093/ajcn/64.5.767. PMID 8901799.
Nakamura Y, Yamamoto N, Sakai K, Takano T (1995). «Antihypertensive effect of sour milk and peptides isolated from it that are inhibitors to angiotensin I-converting enzyme». Journal of Dairy Science. 78 (6): 1253–7. doi:10.3168/jds.S0022-0302(95)76745-5. PMID 7673515.
Boelsma E, Kloek J (2009). «Lactotripeptides and antihypertensive effects: a critical review». The British Journal of Nutrition. 101 (6): 776–86. doi:10.1017/S0007114508137722. PMID 19061526.

globalrph.com

Common Medication Conversions (Equivalents): Ace Inhibitors Արխիվացված 2015-03-17 Wayback Machine. GlobalRPh.com. Accessed 2009-11-22.

handle.net

hdl.handle.net

Molinaro G, Cugno M, Perez M, Lepage Y, Gervais N, Agostoni A, Adam A (2002). «Angiotensin-converting enzyme inhibitor-associated angioedema is characterized by a slower degradation of des-arginine(9)-bradykinin» (PDF). The Journal of Pharmacology and Experimental Therapeutics. 303 (1): 232–7. doi:10.1124/jpet.102.038067. hdl:2434/161106. PMID 12235256.
ONTARGET Investigators; Yusuf, S; Teo, KK; Pogue, J; Dyal, L; Copland, I; Schumacher, H; Dagenais, G; Sleight, P; Anderson, C (2008 թ․ ապրիլի 10). «Telmisartan, ramipril, or both in patients at high risk for vascular events» (PDF). The New England Journal of Medicine. 358 (15): 1547–59. doi:10.1056/NEJMoa0801317. hdl:2437/81925. PMID 18378520.

harvard.edu

ui.adsabs.harvard.edu

Ng KK, Vane JR (1967). «Conversion of Angiotensin I to Angiotensin II». Nature. 216 (5117): 762–6. Bibcode:1967Natur.216..762N. doi:10.1038/216762a0. PMID 4294626.
Ng KK, Vane JR (1968). «Fate of Angiotensin I in the Circulation». Nature. 218 (5137): 144–50. Bibcode:1968Natur.218..144N. doi:10.1038/218144a0. PMID 4296306.
Ng KK, Vane JR (1970). «Some Properties of Angiotensin Converting Enzyme in the Lung in vivo». Nature. 225 (5238): 1142–4. Bibcode:1970Natur.225.1142N. doi:10.1038/2251142b0. PMID 4313869.

medicinenet.com

Ogbru O. «ACE Inhibitors (Angiotensin Converting Enzyme Inhibitors)». MedicineNet.com. MedicineNet, Inc. Արխիվացված օրիգինալից 2010 թ․ մարտի 26-ին. Վերցված է 2010 թ․ մարտի 20-ին.

medscape.com

"Debate: Do ACE Inhibitors Have Unique Properties, Beyond Their Antihypertensive Effect?"
Shelley Wood (2014 թ․ ապրիլի 11). «EMA: Don't Combine ARBs, ACE Inhibitors, and Direct Renin Inhibitors». www.medscape.com.

nice.org.uk

«Type 2 diabetes in adults: management». www.nice.org.uk. National Institute for Health and Care Excellence (NICE). 2017 թ․ մայիս. Վերցված է 2018 թ․ հոկտեմբերի 25-ին.

nih.gov

pubmed.ncbi.nlm.nih.gov

Bangalore, S; Fakheri, R; Wandel, S; Toklu, B; Wandel, J; Messerli, FH (2017 թ․ հունվարի 19). «Renin angiotensin system inhibitors for patients with stable coronary artery disease without heart failure: systematic review and meta-analysis of randomized trials». BMJ (Clinical Research Ed.). 356: j4. doi:10.1136/bmj.j4. PMC 5244819. PMID 28104622.
Caldeira, D.; Alarcao, J.; Vaz-Carneiro, A.; Costa, J. (2012 թ․ հուլիսի 11). «Risk of pneumonia associated with use of angiotensin converting enzyme inhibitors and angiotensin receptor blockers: systematic review and meta-analysis». The BMJ. BMJ. 345 (jul11 1): e4260–e4260. doi:10.1136/bmj.e4260. ISSN 1756-1833. PMC 3394697. PMID 22786934.
Caldeira, Daniel (Summer 2012). «Risk of pneumonia associated with use of angiotensin converting enzyme inhibitors and angiotensin receptor blockers: systematic review and meta-analysis». BMJ. 345: 4260. doi:10.1136/bmj.e4260. PMC 3394697. PMID 22786934.
Dundas, Brian; Harris, Melissa; Narasimhan, Meera (2007 թ․ հուլիսի 3). «Psychogenic polydipsia review: Etiology, differential, and treatment». Current Psychiatry Reports (անգլերեն). 9 (3): 236–241. doi:10.1007/s11920-007-0025-7. ISSN 1523-3812. PMID 17521521.
Greendyke, R. M.; Bernhardt, A. J.; Tasbas, H. E.; Lewandowski, K. S. (1998 թ․ ապրիլի 1). «Polydipsia in chronic psychiatric patients: therapeutic trials of clonidine and enalapril». Neuropsychopharmacology. 18 (4): 272–281. doi:10.1016/S0893-133X(97)00159-0. ISSN 0893-133X. PMID 9509495.
Sebastian, C. S.; Bernardin, A. S. (1990 թ․ ապրիլի 1). «Comparison of enalapril and captopril in the management of self-induced water intoxication». Biological Psychiatry. 27 (7): 787–790. doi:10.1016/0006-3223(90)90594-r. ISSN 0006-3223. PMID 2183881.
Sidorenkov G, Navis G (2014). «Safety of ACE inhibitor therapies in patients with chronic kidney disease». Expert Opinion on Drug Safety. 13 (10): 1383–1395. doi:10.1517/14740338.2014.951328. PMID 25148900.
Thomas MC (2000). «Diuretics, ACE inhibitors and NSAIDs—the triple whammy». The Medical Journal of Australia. 172 (4): 184–5. doi:10.5694/j.1326-5377.2000.tb125548.x. PMID 10772593.
Cohn JN, Kowey PR, Whelton PK, Prisant LM (2000). «New guidelines for potassium replacement in clinical practice: a contemporary review by the National Council on Potassium in Clinical Practice». Archives of Internal Medicine. 160 (16): 2429–36. doi:10.1001/archinte.160.16.2429. PMID 10979053.
OKUMURA, Hiromi; NISHIMURA, Eriko; KARIYA, Satoru; OHTANI, Michiteru; UCHINO, Katsuyoshi; FUKATSU, Tohru; ODANAKA, Jun; TAKAHASHI, Tsuyoshi; WATANABE, Kiyoshi; ITOH, Takashi; HASHIGUCHI, Masayuki; ECHIZEN, Hirotoshi; RIKIHISA, Tadaaki (2001 թ․ մարտի 1). «No Relation between Angiotensin-Converting Enzyme (ACE) Inhibitor-Induced Cough and ACE Gene Polymorphism, Plasma Bradykinin, Substance P and ACE Inhibitor Concentration in Japanese Patients». Yakugaku Zasshi. 121 (3): 253–257. doi:10.1248/yakushi.121.253. PMID 11265121.
Vukadinović, D; Vukadinović, AN; Lavall, D; Laufs, U; Wagenpfeil, S; Böhm, M (2019 թ․ մարտ). «Rate of Cough During Treatment With Angiotensin-Converting Enzyme Inhibitors: A Meta-Analysis of Randomized Placebo-Controlled Trials». Clinical Pharmacology and Therapeutics. 105 (3): 652–660. doi:10.1002/cpt.1018. PMID 29330882.
Bezalel, S; Mahlab-Guri, K; Asher, I; Werner, B; Sthoeger, ZM (2015 թ․ փետրվար). «Angiotensin-converting enzyme inhibitor-induced angioedema». The American Journal of Medicine. 128 (2): 120–5. doi:10.1016/j.amjmed.2014.07.011. PMID 25058867.
Molinaro G, Cugno M, Perez M, Lepage Y, Gervais N, Agostoni A, Adam A (2002). «Angiotensin-converting enzyme inhibitor-associated angioedema is characterized by a slower degradation of des-arginine(9)-bradykinin» (PDF). The Journal of Pharmacology and Experimental Therapeutics. 303 (1): 232–7. doi:10.1124/jpet.102.038067. hdl:2434/161106. PMID 12235256.
Sørensen AM, Christensen S, Jonassen TE, Andersen D, Petersen JS (1998 թ․ մարտ). «[Teratogenic effects of ACE-inhibitors and angiotensin II receptor antagonists]». Ugeskrift for Laeger (Danish). 160 (10): 1460–4. PMID 9520613.{{cite journal}}: CS1 սպաս․ չճանաչված լեզու (link)
Bullo M, Tschumi S, Bucher BS, Bianchetti MG, Simonetti GD (2012). «Pregnancy Outcome Following Exposure to Angiotensin-Converting Enzyme Inhibitors or Angiotensin Receptor Antagonists: A Systematic Review». Hypertension. 60 (2): 444–50. doi:10.1161/HYPERTENSIONAHA.112.196352. PMID 22753220.
Cooper WO, Hernandez-Diaz S, Arbogast PG, Dudley JA, Dyer S, Gideon PS, Hall K, Ray WA (2006). «Major congenital malformations after first-trimester exposure to ACE inhibitors». The New England Journal of Medicine. 354 (23): 2443–51. doi:10.1056/NEJMoa055202. PMID 16760444.
Bakris GL, Siomos M, Richardson D, Janssen I, Bolton WK, Hebert L, Agarwal R, Catanzaro D (2000 թ․ նոյեմբեր). «ACE inhibition or angiotensin receptor blockade: impact on potassium in renal failure. VAL-K Study Group». Kidney International. 58 (5): 2084–92. doi:10.1111/j.1523-1755.2000.00381.x. PMID 11044229.
Jandeleit-Dahm K, Cooper ME (2006 թ․ սեպտեմբեր). «Hypertension and diabetes: role of the renin–angiotensin system». Endocrinol Metab Clin North Am. 35 (3): 469–90, vii. doi:10.1016/j.ecl.2006.06.007. PMID 16959581.
Wang W, McKinnie SM, Farhan M, Paul M, McDonald T, McLean B, Llorens-Cortes C, Hazra S, Murray AG, Vederas JC, Oudit GY (2016 թ․ մայիս). «Angiotensin Converting Enzyme 2 Metabolizes and Partially Inactivates Pyrapelin-13 and Apelin-17: Physiological Effects in the Cardiovascular System». Hypertension. 68 (2): 365–77. doi:10.1161/HYPERTENSIONAHA.115.06892. PMID 27217402.
Hoogwerf BJ, Young JB (2000). «The HOPE study. Ramipril lowered cardiovascular risk, but vitamin E did not». Cleveland Clinic Journal of Medicine. 67 (4): 287–93. doi:10.3949/ccjm.67.4.287. PMID 10780101.
Ajayi AA, Campbell BC, Howie CA, Reid JL (1985). «Acute and Chronic Effects of the Converting Enzyme Inhibitors Enalapril and Lisinopril on Reflex Control of Heart Rate in Normotensive Man». Journal of Hypertension. 3 (1): 47–53. doi:10.1097/00004872-198502000-00008. PMID 2987341.
Adigun AQ, Asiyanbola B, Ajayi AA (2001). «Cardiac autonomic function in Blacks with congestive heart failure: vagomimetic action, alteration in sympathovagal balance, and the effect of ACE inhibition on central and peripheral vagal tone». Cell Mol Biol (Noisy le Grande). 47 (6): 1063–7. PMID 11785658.Կաղապար:Verify source
Binkley PF, Haas GJ, Starling RC, Nunziata E, Hatton PA, Leier CV, Cody RJ (1993 թ․ մարտի 1). «Sustained augmentation of parasympathetic tone with angiotensin-converting enzyme inhibition in patients with congestive heart failure». J Am Coll Cardiol. 21 (3): 655–61. doi:10.1016/0735-1097(93)90098-L. PMID 8436747.
Adigun AQ, Ajayi AA (2001). «The effects of enalapril-digoxin-diuretic combination therapy on nutritional and anthropometric indices in chronic congestive heart failure: preliminary findings in cardiac cachexia». European Journal of Heart Failure. 3 (3): 359–63. doi:10.1016/S1388-9842(00)00146-X. PMID 11378008.
Anker SD, Ponikowski P, Varney S, Chua TP, Clark AL, Webb-Peploe KM, Harrington D, Kox WJ, Poole-Wilson PA, Coats AJ (1997). «Wasting as independent risk factor for mortality in chronic heart failure». The Lancet. 349 (9058): 1050–3. doi:10.1016/S0140-6736(96)07015-8. PMID 9107242.
von Haehling S, Morley JE, Anker SD (2010 թ․ դեկտեմբեր). «An overview of sarcopenia: facts and numbers on prevalence and clinical impact». J Cachexia Sarcopenia Muscle. 1 (2): 129–133. doi:10.1007/s13539-010-0014-2. PMC 3060646. PMID 21475695.
Kumar R, Chaudhary K, Sharma M, Nagpal G, Chauhan JS, Singh S, Gautam A, Raghava GP (2015). «AHTPDB: a comprehensive platform for analysis and presentation of antihypertensive peptides». Nucleic Acids Res. 43 (Database issue): D956–62. doi:10.1093/nar/gku1141. PMC 4383949. PMID 25392419.
FitzGerald RJ, Murray BA, Walsh DJ (2004). «Hypotensive peptides from milk proteins». The Journal of Nutrition. 134 (4): 980S–8S. doi:10.1093/jn/134.4.980S. PMID 15051858.
Aihara K, Kajimoto O, Hirata H, Takahashi R, Nakamura Y (2005). «Effect of powdered fermented milk with Lactobacillus helveticus on subjects with high-normal blood pressure or mild hypertension». Journal of the American College of Nutrition. 24 (4): 257–65. doi:10.1080/07315724.2005.10719473. PMID 16093403.
Minervini, F.; Algaron, F.; Rizzello, C. G.; Fox, P. F.; Monnet, V. (2003). «Angiotensin I-Converting-Enzyme-Inhibitory and Antibacterial Peptides from Lactobacillus helveticus PR4 Proteinase-Hydrolyzed Caseins of Milk from Six Species». Applied and Environmental Microbiology. 69 (9): 5297–5305. doi:10.1128/AEM.69.9.5297-5305.2003. PMC 194939. PMID 12957917.
The Acute Infarction Ramipril Efficacy (AIRE) Study Investigators (1993 թ․ հոկտեմբեր). «Effect of ramipril on mortality and morbidity of survivors of acute myocardial infarction with clinical evidence of heart failure». Lancet. 342 (8875): 821–8. doi:10.1016/0140-6736(93)92693-N. PMID 8104270.
van Vark LC, Bertrand M, Akkerhuis KM, Brugts JJ, Fox K, Mourad JJ, Boersma E (2012). «Angiotensin-converting enzyme inhibitors reduce mortality in hypertension: a meta-analysis of randomized clinical trials of renin–angiotensin–aldosterone system inhibitors involving 158,998 patients». Eur Heart J. 33 (16): 2088–97. doi:10.1093/eurheartj/ehs075. PMC 3418510. PMID 22511654.
Dimopoulos NA, Salukhe TV, Coats AJ, Mayet J, Piepoli M, Francis DP (2004). «Meta-analyses of mortality and morbidity effects of an angiotensin receptor blocker in patients with chronic heart failure already receiving an ACE inhibitor (alone or with a beta-blocker)». Int J Cardiol. 93 (2): 105–111. doi:10.1016/j.ijcard.2003.10.001. PMID 14975535.
Luno J, Praga M, de Vinuesa SG (2005). «The reno-protective effect of the dual blockade of the renin angiotensin system (RAS)». Current Pharmaceutical Design. 11 (10): 1291–300. doi:10.2174/1381612053507413. PMID 15853685.
van de Wal RM, van Veldhuisen DJ, van Gilst WH, Voors AA (2005). «Addition of an angiotensin receptor blocker to full-dose ACE-inhibition: controversial or common sense?». European Heart Journal. 26 (22): 2361–7. doi:10.1093/eurheartj/ehi454. PMID 16105846.
ONTARGET Investigators; Yusuf, S; Teo, KK; Pogue, J; Dyal, L; Copland, I; Schumacher, H; Dagenais, G; Sleight, P; Anderson, C (2008 թ․ ապրիլի 10). «Telmisartan, ramipril, or both in patients at high risk for vascular events» (PDF). The New England Journal of Medicine. 358 (15): 1547–59. doi:10.1056/NEJMoa0801317. hdl:2437/81925. PMID 18378520.
Finnegan PM, Gleason BL (2003). «Combination ACE inhibitors and angiotensin II receptor blockers for hypertension». Annals of Pharmacotherapy. 37 (6): 886–9. doi:10.1345/aph.1C393. PMID 12773079.
Krum H, Carson P, Farsang C, Maggioni AP, Glazer RD, Aknay N, Chiang YT, Cohn JN (2004). «Effect of valsartan added to background ACE inhibitor therapy in patients with heart failure: results from Val-HeFT». European Journal of Heart Failure. 6 (7): 937–45. doi:10.1016/j.ejheart.2004.09.005. PMID 15556056.
Solomon SD, Skali H, Anavekar NS, Bourgoun M, Barvik S, Ghali JK, Warnica JW, Khrakovskaya M, Arnold JM, Schwartz Y, Velazquez EJ, Califf RM, McMurray JV, Pfeffer MA (2005). «Changes in Ventricular Size and Function in Patients Treated with Valsartan, Captopril, or Both After Myocardial Infarction». Circulation. 111 (25): 3411–3419. doi:10.1161/CIRCULATIONAHA.104.508093. PMID 15967846.
Yang Y, Ohta K, Shimizu M, Nakai A, Kasahara Y, Yachie A, Koizumi S (2005 թ․ հուլիս). «Treatment with low-dose angiotensin-converting enzyme inhibitor (ACEI) plus angiotensin II receptor blocker (ARB) in pediatric patients with IgA nephropathy». Clinical Nephrology. 64 (1): 35–40. doi:10.5414/CNP64035. PMID 16047643.
Ferreira SH (1965 թ․ փետրվար). «A bradykinin-potentiating factor (bpf) present in the venom of bothrops jararaca». Br J Pharmacol Chemother. 24 (1): 163–9. doi:10.1111/j.1476-5381.1965.tb02091.x. PMC 1704050. PMID 14302350.
Ng KK, Vane JR (1967). «Conversion of Angiotensin I to Angiotensin II». Nature. 216 (5117): 762–6. Bibcode:1967Natur.216..762N. doi:10.1038/216762a0. PMID 4294626.
Ng KK, Vane JR (1968). «Fate of Angiotensin I in the Circulation». Nature. 218 (5137): 144–50. Bibcode:1968Natur.218..144N. doi:10.1038/218144a0. PMID 4296306.
Ng KK, Vane JR (1970). «Some Properties of Angiotensin Converting Enzyme in the Lung in vivo». Nature. 225 (5238): 1142–4. Bibcode:1970Natur.225.1142N. doi:10.1038/2251142b0. PMID 4313869.
Hata Y, Yamamoto M, Ohni M, Nakajima K, Nakamura Y, Takano T (1996). «A placebo-controlled study of the effect of sour milk on blood pressure in hypertensive subjects». The American Journal of Clinical Nutrition. 64 (5): 767–71. doi:10.1093/ajcn/64.5.767. PMID 8901799.
Nakamura Y, Yamamoto N, Sakai K, Takano T (1995). «Antihypertensive effect of sour milk and peptides isolated from it that are inhibitors to angiotensin I-converting enzyme». Journal of Dairy Science. 78 (6): 1253–7. doi:10.3168/jds.S0022-0302(95)76745-5. PMID 7673515.
Boelsma E, Kloek J (2009). «Lactotripeptides and antihypertensive effects: a critical review». The British Journal of Nutrition. 101 (6): 776–86. doi:10.1017/S0007114508137722. PMID 19061526.

ncbi.nlm.nih.gov

Bangalore, S; Fakheri, R; Wandel, S; Toklu, B; Wandel, J; Messerli, FH (2017 թ․ հունվարի 19). «Renin angiotensin system inhibitors for patients with stable coronary artery disease without heart failure: systematic review and meta-analysis of randomized trials». BMJ (Clinical Research Ed.). 356: j4. doi:10.1136/bmj.j4. PMC 5244819. PMID 28104622.
Caldeira, D.; Alarcao, J.; Vaz-Carneiro, A.; Costa, J. (2012 թ․ հուլիսի 11). «Risk of pneumonia associated with use of angiotensin converting enzyme inhibitors and angiotensin receptor blockers: systematic review and meta-analysis». The BMJ. BMJ. 345 (jul11 1): e4260–e4260. doi:10.1136/bmj.e4260. ISSN 1756-1833. PMC 3394697. PMID 22786934.
Caldeira, Daniel (Summer 2012). «Risk of pneumonia associated with use of angiotensin converting enzyme inhibitors and angiotensin receptor blockers: systematic review and meta-analysis». BMJ. 345: 4260. doi:10.1136/bmj.e4260. PMC 3394697. PMID 22786934.
von Haehling S, Morley JE, Anker SD (2010 թ․ դեկտեմբեր). «An overview of sarcopenia: facts and numbers on prevalence and clinical impact». J Cachexia Sarcopenia Muscle. 1 (2): 129–133. doi:10.1007/s13539-010-0014-2. PMC 3060646. PMID 21475695.
Kumar R, Chaudhary K, Sharma M, Nagpal G, Chauhan JS, Singh S, Gautam A, Raghava GP (2015). «AHTPDB: a comprehensive platform for analysis and presentation of antihypertensive peptides». Nucleic Acids Res. 43 (Database issue): D956–62. doi:10.1093/nar/gku1141. PMC 4383949. PMID 25392419.
Minervini, F.; Algaron, F.; Rizzello, C. G.; Fox, P. F.; Monnet, V. (2003). «Angiotensin I-Converting-Enzyme-Inhibitory and Antibacterial Peptides from Lactobacillus helveticus PR4 Proteinase-Hydrolyzed Caseins of Milk from Six Species». Applied and Environmental Microbiology. 69 (9): 5297–5305. doi:10.1128/AEM.69.9.5297-5305.2003. PMC 194939. PMID 12957917.
van Vark LC, Bertrand M, Akkerhuis KM, Brugts JJ, Fox K, Mourad JJ, Boersma E (2012). «Angiotensin-converting enzyme inhibitors reduce mortality in hypertension: a meta-analysis of randomized clinical trials of renin–angiotensin–aldosterone system inhibitors involving 158,998 patients». Eur Heart J. 33 (16): 2088–97. doi:10.1093/eurheartj/ehs075. PMC 3418510. PMID 22511654.
Ferreira SH (1965 թ․ փետրվար). «A bradykinin-potentiating factor (bpf) present in the venom of bothrops jararaca». Br J Pharmacol Chemother. 24 (1): 163–9. doi:10.1111/j.1476-5381.1965.tb02091.x. PMC 1704050. PMID 14302350.

openanesthesia.org

«ACEI contraindications». Open Anesthesia.

patents.google.com

«US4013791A - Peptides having an antihypertensive effect». Google Patents. 1975 թ․ դեկտեմբերի 3. Վերցված է 2020 թ․ մարտի 21-ին.

rxmed.com

FDA Prescribing information, http://www.rxmed.com/b.main/b2.pharmaceutical/b2.1.monographs/CPS-%20Monographs/CPS-%20%28General%20Monographs-%20A%29/ACE%20INHIBITORS.html
«ACE Inhibitors». RxMed.com. Վերցված է 2018 թ․ սեպտեմբերի 20-ին.

tripanswers.org

What are the dose comparisons of all ACE inhibitors used in hypertension? Արխիվացված 2015-04-02 Wayback Machine TripAnswers, Trip, May 25, 2007. Accessed 2009-11-21

unideb.hu

dea.lib.unideb.hu

ONTARGET Investigators; Yusuf, S; Teo, KK; Pogue, J; Dyal, L; Copland, I; Schumacher, H; Dagenais, G; Sleight, P; Anderson, C (2008 թ․ ապրիլի 10). «Telmisartan, ramipril, or both in patients at high risk for vascular events» (PDF). The New England Journal of Medicine. 358 (15): 1547–59. doi:10.1056/NEJMoa0801317. hdl:2437/81925. PMID 18378520.

unimi.it

air.unimi.it

Molinaro G, Cugno M, Perez M, Lepage Y, Gervais N, Agostoni A, Adam A (2002). «Angiotensin-converting enzyme inhibitor-associated angioedema is characterized by a slower degradation of des-arginine(9)-bradykinin» (PDF). The Journal of Pharmacology and Experimental Therapeutics. 303 (1): 232–7. doi:10.1124/jpet.102.038067. hdl:2434/161106. PMID 12235256.

web.archive.org

«Psychogenic polydipsia – Management – Emerging treatments». British Medical Journal. 2016 թ․ մայիսի 5. Արխիվացված է օրիգինալից 2021 թ․ օգոստոսի 27-ին. Վերցված է 2016 թ․ հոկտեմբերի 28-ին.
Ogbru O. «ACE Inhibitors (Angiotensin Converting Enzyme Inhibitors)». MedicineNet.com. MedicineNet, Inc. Արխիվացված օրիգինալից 2010 թ․ մարտի 26-ին. Վերցված է 2010 թ․ մարտի 20-ին.
What are the dose comparisons of all ACE inhibitors used in hypertension? Արխիվացված 2015-04-02 Wayback Machine TripAnswers, Trip, May 25, 2007. Accessed 2009-11-21
Common Medication Conversions (Equivalents): Ace Inhibitors Արխիվացված 2015-03-17 Wayback Machine. GlobalRPh.com. Accessed 2009-11-22.

worldcat.org

Caldeira, D.; Alarcao, J.; Vaz-Carneiro, A.; Costa, J. (2012 թ․ հուլիսի 11). «Risk of pneumonia associated with use of angiotensin converting enzyme inhibitors and angiotensin receptor blockers: systematic review and meta-analysis». The BMJ. BMJ. 345 (jul11 1): e4260–e4260. doi:10.1136/bmj.e4260. ISSN 1756-1833. PMC 3394697. PMID 22786934.
Dundas, Brian; Harris, Melissa; Narasimhan, Meera (2007 թ․ հուլիսի 3). «Psychogenic polydipsia review: Etiology, differential, and treatment». Current Psychiatry Reports (անգլերեն). 9 (3): 236–241. doi:10.1007/s11920-007-0025-7. ISSN 1523-3812. PMID 17521521.
Greendyke, R. M.; Bernhardt, A. J.; Tasbas, H. E.; Lewandowski, K. S. (1998 թ․ ապրիլի 1). «Polydipsia in chronic psychiatric patients: therapeutic trials of clonidine and enalapril». Neuropsychopharmacology. 18 (4): 272–281. doi:10.1016/S0893-133X(97)00159-0. ISSN 0893-133X. PMID 9509495.
Sebastian, C. S.; Bernardin, A. S. (1990 թ․ ապրիլի 1). «Comparison of enalapril and captopril in the management of self-induced water intoxication». Biological Psychiatry. 27 (7): 787–790. doi:10.1016/0006-3223(90)90594-r. ISSN 0006-3223. PMID 2183881.